BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2285230)

  • 1. Metastatic phenotype: growth factor dependence and integrin expression.
    Perrotti D; Cimino L; Falcioni R; Tibursi G; Gentileschi MP; Sacchi A
    Anticancer Res; 1990; 10(6):1587-97. PubMed ID: 2285230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of transforming growth factor-beta 1 gene in 3LL metastatic variants.
    Perrotti D; Cimino L; Ferrari S; Sacchi A
    Cancer Res; 1991 Oct; 51(20):5491-4. PubMed ID: 1913669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective down-regulation of integrin receptors in spheroids of squamous cell carcinoma.
    Waleh NS; Gallo J; Grant TD; Murphy BJ; Kramer RH; Sutherland RM
    Cancer Res; 1994 Feb; 54(3):838-43. PubMed ID: 8306347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced phosphorylation of a murine tumor surface protein (TSP-180) associated with metastatic phenotype.
    Sacchi A; Falcioni R; Piaggio G; Gianfelice MA; Perrotti N; Kennel SJ
    Cancer Res; 1989 May; 49(10):2615-20. PubMed ID: 2713845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of PDGFalpha receptor expression or function alters the metastatic phenotype of 3LL cells.
    Fitzer-Attas CJ; Do MS; Feigelson S; Vadai E; Feldman M; Eisenbach L
    Oncogene; 1997 Sep; 15(13):1545-54. PubMed ID: 9380406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 1 integrin expression on human small cell lung cancer cells.
    Feldman LE; Shin KC; Natale RB; Todd RF
    Cancer Res; 1991 Feb; 51(4):1065-70. PubMed ID: 1705164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo.
    Theodorescu D; Caltabiano M; Greig R; Rieman D; Kerbel RS
    J Cell Physiol; 1991 Sep; 148(3):380-90. PubMed ID: 1655815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 suppresses transformation in hepatocytes by regulating alpha 1 beta 1 integrin expression.
    Serra R; Carbonetto S; Lord M; Isom HC
    Cell Growth Differ; 1994 May; 5(5):509-17. PubMed ID: 8049157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.
    Schwarz LC; Gingras MC; Goldberg G; Greenberg AH; Wright JA
    Cancer Res; 1988 Dec; 48(24 Pt 1):6999-7003. PubMed ID: 3056609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon cancer cells adhesion and spreading on autocrine laminin-10 is mediated by multiple integrin receptors and modulated by EGF receptor stimulation.
    Pouliot N; Connolly LM; Moritz RL; Simpson RJ; Burgess AW
    Exp Cell Res; 2000 Dec; 261(2):360-71. PubMed ID: 11112342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
    Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A
    Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse platelet-derived growth factor alpha receptor: sequence, tissue-specific expression and correlation with metastatic phenotype.
    Do MS; Fitzer-Attas C; Gubbay J; Greenfeld L; Feldman M; Eisenbach L
    Oncogene; 1992 Aug; 7(8):1567-75. PubMed ID: 1321404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of transforming growth factor beta 1 on the growth of poorly and highly metastatic murine melanoma cells.
    Mooradian DL; Purchio AF; Furcht LT
    Cancer Res; 1990 Jan; 50(2):273-7. PubMed ID: 2295066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective changes in laminin adhesion and alpha 6 beta 4 integrin regulation are associated with the initial steps in keratinocyte maturation.
    Tennenbaum T; Li L; Belanger AJ; De Luca LM; Yuspa SH
    Cell Growth Differ; 1996 May; 7(5):615-28. PubMed ID: 8732671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins.
    Ruiz P; Dunon D; Sonnenberg A; Imhof BA
    Cell Adhes Commun; 1993 May; 1(1):67-81. PubMed ID: 8081871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors.
    Droz D; Patey N; Paraf F; Chrétien Y; Gogusev J
    Lab Invest; 1994 Nov; 71(5):710-8. PubMed ID: 7526040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions.
    Bozzo C; Bellomo G; Silengo L; Tarone G; Altruda F
    Exp Cell Res; 1997 Dec; 237(2):326-37. PubMed ID: 9434628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.